nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaprozin—PTGS2—bone cancer	0.735	1	CbGaD
Oxaprozin—PTGS2—Cisplatin—bone cancer	0.0928	0.746	CbGbCtD
Oxaprozin—CYP2C9—Cisplatin—bone cancer	0.0315	0.254	CbGbCtD
Oxaprozin—Fenbufen—PTGS2—bone cancer	0.00073	0.132	CrCbGaD
Oxaprozin—Bifonazole—CYP3A4—bone cancer	0.000511	0.0925	CrCbGaD
Oxaprozin—Phenprocoumon—CYP3A4—bone cancer	0.000462	0.0837	CrCbGaD
Oxaprozin—Dermatitis exfoliative—Epirubicin—bone cancer	0.000441	0.00327	CcSEcCtD
Oxaprozin—Malaise—Cisplatin—bone cancer	0.00044	0.00326	CcSEcCtD
Oxaprozin—Photosensitivity—Doxorubicin—bone cancer	0.000438	0.00325	CcSEcCtD
Oxaprozin—Renal impairment—Epirubicin—bone cancer	0.000437	0.00324	CcSEcCtD
Oxaprozin—Leukopenia—Cisplatin—bone cancer	0.000436	0.00324	CcSEcCtD
Oxaprozin—Purpura—Epirubicin—bone cancer	0.000431	0.0032	CcSEcCtD
Oxaprozin—Vascular purpura—Doxorubicin—bone cancer	0.00043	0.00319	CcSEcCtD
Oxaprozin—Anaphylactoid reaction—Epirubicin—bone cancer	0.00043	0.00319	CcSEcCtD
Oxaprozin—Phenylbutazone—CYP3A4—bone cancer	0.000428	0.0776	CrCbGaD
Oxaprozin—Hepatic failure—Doxorubicin—bone cancer	0.000428	0.00318	CcSEcCtD
Oxaprozin—Lethargy—Epirubicin—bone cancer	0.000424	0.00315	CcSEcCtD
Oxaprozin—Cardiac failure congestive—Doxorubicin—bone cancer	0.000424	0.00315	CcSEcCtD
Oxaprozin—Convulsion—Cisplatin—bone cancer	0.000422	0.00314	CcSEcCtD
Oxaprozin—Phenylbutazone—PTGS2—bone cancer	0.00042	0.076	CrCbGaD
Oxaprozin—Renal failure acute—Doxorubicin—bone cancer	0.000417	0.00309	CcSEcCtD
Oxaprozin—Gastrointestinal haemorrhage—Epirubicin—bone cancer	0.000416	0.00309	CcSEcCtD
Oxaprozin—Anxiety—Cisplatin—bone cancer	0.000414	0.00307	CcSEcCtD
Oxaprozin—Discomfort—Cisplatin—bone cancer	0.00041	0.00304	CcSEcCtD
Oxaprozin—Warfarin—CYP3A4—bone cancer	0.00041	0.0742	CrCbGaD
Oxaprozin—Dermatitis exfoliative—Doxorubicin—bone cancer	0.000408	0.00303	CcSEcCtD
Oxaprozin—Renal impairment—Doxorubicin—bone cancer	0.000404	0.003	CcSEcCtD
Oxaprozin—Propafenone—CYP3A4—bone cancer	0.0004	0.0726	CrCbGaD
Oxaprozin—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.0004	0.00297	CcSEcCtD
Oxaprozin—Purpura—Doxorubicin—bone cancer	0.000399	0.00296	CcSEcCtD
Oxaprozin—Anaphylactic shock—Cisplatin—bone cancer	0.000398	0.00295	CcSEcCtD
Oxaprozin—Oedema—Cisplatin—bone cancer	0.000398	0.00295	CcSEcCtD
Oxaprozin—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000397	0.00295	CcSEcCtD
Oxaprozin—Infection—Cisplatin—bone cancer	0.000395	0.00293	CcSEcCtD
Oxaprozin—Lethargy—Doxorubicin—bone cancer	0.000393	0.00291	CcSEcCtD
Oxaprozin—Thrombocytopenia—Cisplatin—bone cancer	0.00039	0.00289	CcSEcCtD
Oxaprozin—Tachycardia—Cisplatin—bone cancer	0.000388	0.00288	CcSEcCtD
Oxaprozin—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	0.000385	0.00286	CcSEcCtD
Oxaprozin—Hyperhidrosis—Cisplatin—bone cancer	0.000385	0.00286	CcSEcCtD
Oxaprozin—Asthma—Methotrexate—bone cancer	0.000384	0.00285	CcSEcCtD
Oxaprozin—Eosinophilia—Methotrexate—bone cancer	0.00038	0.00282	CcSEcCtD
Oxaprozin—Abdominal pain upper—Epirubicin—bone cancer	0.00038	0.00282	CcSEcCtD
Oxaprozin—Anorexia—Cisplatin—bone cancer	0.000379	0.00282	CcSEcCtD
Oxaprozin—Pancreatitis—Methotrexate—bone cancer	0.000376	0.00279	CcSEcCtD
Oxaprozin—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000374	0.00278	CcSEcCtD
Oxaprozin—Hypotension—Cisplatin—bone cancer	0.000372	0.00276	CcSEcCtD
Oxaprozin—Gastritis—Epirubicin—bone cancer	0.000368	0.00273	CcSEcCtD
Oxaprozin—Pancytopenia—Methotrexate—bone cancer	0.000365	0.00271	CcSEcCtD
Oxaprozin—Clorazepate—CYP3A4—bone cancer	0.000361	0.0653	CrCbGaD
Oxaprozin—Asthma—Epirubicin—bone cancer	0.000359	0.00267	CcSEcCtD
Oxaprozin—Dysuria—Methotrexate—bone cancer	0.000359	0.00267	CcSEcCtD
Oxaprozin—Paraesthesia—Cisplatin—bone cancer	0.000357	0.00265	CcSEcCtD
Oxaprozin—Eosinophilia—Epirubicin—bone cancer	0.000356	0.00264	CcSEcCtD
Oxaprozin—Dyspnoea—Cisplatin—bone cancer	0.000355	0.00263	CcSEcCtD
Oxaprozin—Pancreatitis—Epirubicin—bone cancer	0.000352	0.00262	CcSEcCtD
Oxaprozin—Abdominal pain upper—Doxorubicin—bone cancer	0.000351	0.00261	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Methotrexate—bone cancer	0.00035	0.0026	CcSEcCtD
Oxaprozin—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000346	0.00257	CcSEcCtD
Oxaprozin—Decreased appetite—Cisplatin—bone cancer	0.000346	0.00257	CcSEcCtD
Oxaprozin—Pneumonia—Methotrexate—bone cancer	0.000344	0.00256	CcSEcCtD
Oxaprozin—Drowsiness—Methotrexate—bone cancer	0.000342	0.00254	CcSEcCtD
Oxaprozin—Flurbiprofen—PTGS2—bone cancer	0.000342	0.062	CrCbGaD
Oxaprozin—Pancytopenia—Epirubicin—bone cancer	0.000341	0.00253	CcSEcCtD
Oxaprozin—Gastritis—Doxorubicin—bone cancer	0.00034	0.00253	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000339	0.00252	CcSEcCtD
Oxaprozin—Renal failure—Methotrexate—bone cancer	0.000337	0.0025	CcSEcCtD
Oxaprozin—Dysuria—Epirubicin—bone cancer	0.000336	0.00249	CcSEcCtD
Oxaprozin—Modafinil—CYP3A4—bone cancer	0.000336	0.0608	CrCbGaD
Oxaprozin—Stomatitis—Methotrexate—bone cancer	0.000334	0.00248	CcSEcCtD
Oxaprozin—Conjunctivitis—Methotrexate—bone cancer	0.000333	0.00247	CcSEcCtD
Oxaprozin—Asthma—Doxorubicin—bone cancer	0.000332	0.00247	CcSEcCtD
Oxaprozin—Eosinophilia—Doxorubicin—bone cancer	0.000329	0.00244	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Epirubicin—bone cancer	0.000328	0.00243	CcSEcCtD
Oxaprozin—Feeling abnormal—Cisplatin—bone cancer	0.000328	0.00243	CcSEcCtD
Oxaprozin—Haematuria—Methotrexate—bone cancer	0.000326	0.00242	CcSEcCtD
Oxaprozin—Pancreatitis—Doxorubicin—bone cancer	0.000326	0.00242	CcSEcCtD
Oxaprozin—Hyperglycaemia—Epirubicin—bone cancer	0.000324	0.00241	CcSEcCtD
Oxaprozin—Pneumonia—Epirubicin—bone cancer	0.000322	0.00239	CcSEcCtD
Oxaprozin—Drowsiness—Epirubicin—bone cancer	0.00032	0.00238	CcSEcCtD
Oxaprozin—Agranulocytosis—Methotrexate—bone cancer	0.000319	0.00237	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000318	0.00236	CcSEcCtD
Oxaprozin—Pancytopenia—Doxorubicin—bone cancer	0.000316	0.00234	CcSEcCtD
Oxaprozin—Renal failure—Epirubicin—bone cancer	0.000315	0.00234	CcSEcCtD
Oxaprozin—Body temperature increased—Cisplatin—bone cancer	0.000315	0.00234	CcSEcCtD
Oxaprozin—Jaundice—Epirubicin—bone cancer	0.000312	0.00232	CcSEcCtD
Oxaprozin—Stomatitis—Epirubicin—bone cancer	0.000312	0.00232	CcSEcCtD
Oxaprozin—Conjunctivitis—Epirubicin—bone cancer	0.000311	0.00231	CcSEcCtD
Oxaprozin—Dysuria—Doxorubicin—bone cancer	0.000311	0.00231	CcSEcCtD
Oxaprozin—Haemoglobin—Methotrexate—bone cancer	0.000309	0.00229	CcSEcCtD
Oxaprozin—Haemorrhage—Methotrexate—bone cancer	0.000307	0.00228	CcSEcCtD
Oxaprozin—Hepatitis—Methotrexate—bone cancer	0.000307	0.00228	CcSEcCtD
Oxaprozin—Carbamazepine—CYP3A4—bone cancer	0.000306	0.0555	CrCbGaD
Oxaprozin—Haematuria—Epirubicin—bone cancer	0.000305	0.00227	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Doxorubicin—bone cancer	0.000303	0.00225	CcSEcCtD
Oxaprozin—Sinusitis—Epirubicin—bone cancer	0.000301	0.00223	CcSEcCtD
Oxaprozin—Hyperglycaemia—Doxorubicin—bone cancer	0.0003	0.00223	CcSEcCtD
Oxaprozin—Agranulocytosis—Epirubicin—bone cancer	0.000299	0.00222	CcSEcCtD
Oxaprozin—Pneumonia—Doxorubicin—bone cancer	0.000298	0.00221	CcSEcCtD
Oxaprozin—Phenytoin—CYP3A4—bone cancer	0.000298	0.0539	CrCbGaD
Oxaprozin—Drowsiness—Doxorubicin—bone cancer	0.000296	0.0022	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000294	0.00218	CcSEcCtD
Oxaprozin—Renal failure—Doxorubicin—bone cancer	0.000291	0.00216	CcSEcCtD
Oxaprozin—Benzphetamine—CYP3A4—bone cancer	0.000291	0.0527	CrCbGaD
Oxaprozin—Erythema multiforme—Methotrexate—bone cancer	0.000291	0.00216	CcSEcCtD
Oxaprozin—Haemoglobin—Epirubicin—bone cancer	0.000289	0.00215	CcSEcCtD
Oxaprozin—Stomatitis—Doxorubicin—bone cancer	0.000289	0.00215	CcSEcCtD
Oxaprozin—Jaundice—Doxorubicin—bone cancer	0.000289	0.00215	CcSEcCtD
Oxaprozin—Conjunctivitis—Doxorubicin—bone cancer	0.000288	0.00214	CcSEcCtD
Oxaprozin—Hepatitis—Epirubicin—bone cancer	0.000288	0.00214	CcSEcCtD
Oxaprozin—Haemorrhage—Epirubicin—bone cancer	0.000288	0.00214	CcSEcCtD
Oxaprozin—Tinnitus—Methotrexate—bone cancer	0.000287	0.00213	CcSEcCtD
Oxaprozin—Asthenia—Cisplatin—bone cancer	0.000285	0.00212	CcSEcCtD
Oxaprozin—Haematuria—Doxorubicin—bone cancer	0.000283	0.0021	CcSEcCtD
Oxaprozin—Sinusitis—Doxorubicin—bone cancer	0.000278	0.00206	CcSEcCtD
Oxaprozin—Agranulocytosis—Doxorubicin—bone cancer	0.000277	0.00205	CcSEcCtD
Oxaprozin—Diarrhoea—Cisplatin—bone cancer	0.000272	0.00202	CcSEcCtD
Oxaprozin—Erythema multiforme—Epirubicin—bone cancer	0.000272	0.00202	CcSEcCtD
Oxaprozin—Alopecia—Methotrexate—bone cancer	0.000272	0.00202	CcSEcCtD
Oxaprozin—Tinnitus—Epirubicin—bone cancer	0.000268	0.00199	CcSEcCtD
Oxaprozin—Haemoglobin—Doxorubicin—bone cancer	0.000267	0.00199	CcSEcCtD
Oxaprozin—Haemorrhage—Doxorubicin—bone cancer	0.000266	0.00198	CcSEcCtD
Oxaprozin—Hepatitis—Doxorubicin—bone cancer	0.000266	0.00198	CcSEcCtD
Oxaprozin—Dysgeusia—Methotrexate—bone cancer	0.000262	0.00194	CcSEcCtD
Oxaprozin—Arrhythmia—Epirubicin—bone cancer	0.000257	0.00191	CcSEcCtD
Oxaprozin—Alopecia—Epirubicin—bone cancer	0.000254	0.00189	CcSEcCtD
Oxaprozin—Vomiting—Cisplatin—bone cancer	0.000253	0.00188	CcSEcCtD
Oxaprozin—Vision blurred—Methotrexate—bone cancer	0.000252	0.00187	CcSEcCtD
Oxaprozin—Erythema multiforme—Doxorubicin—bone cancer	0.000252	0.00187	CcSEcCtD
Oxaprozin—Rash—Cisplatin—bone cancer	0.000251	0.00186	CcSEcCtD
Oxaprozin—Dermatitis—Cisplatin—bone cancer	0.000251	0.00186	CcSEcCtD
Oxaprozin—Ill-defined disorder—Methotrexate—bone cancer	0.000248	0.00184	CcSEcCtD
Oxaprozin—Tinnitus—Doxorubicin—bone cancer	0.000248	0.00184	CcSEcCtD
Oxaprozin—Anaemia—Methotrexate—bone cancer	0.000247	0.00184	CcSEcCtD
Oxaprozin—Flatulence—Epirubicin—bone cancer	0.000247	0.00183	CcSEcCtD
Oxaprozin—Tension—Epirubicin—bone cancer	0.000246	0.00182	CcSEcCtD
Oxaprozin—Dysgeusia—Epirubicin—bone cancer	0.000245	0.00182	CcSEcCtD
Oxaprozin—Nervousness—Epirubicin—bone cancer	0.000243	0.00181	CcSEcCtD
Oxaprozin—Malaise—Methotrexate—bone cancer	0.000241	0.00179	CcSEcCtD
Oxaprozin—Vertigo—Methotrexate—bone cancer	0.00024	0.00178	CcSEcCtD
Oxaprozin—Leukopenia—Methotrexate—bone cancer	0.000239	0.00178	CcSEcCtD
Oxaprozin—Arrhythmia—Doxorubicin—bone cancer	0.000238	0.00176	CcSEcCtD
Oxaprozin—Nausea—Cisplatin—bone cancer	0.000236	0.00175	CcSEcCtD
Oxaprozin—Vision blurred—Epirubicin—bone cancer	0.000236	0.00175	CcSEcCtD
Oxaprozin—Alopecia—Doxorubicin—bone cancer	0.000235	0.00175	CcSEcCtD
Oxaprozin—Ill-defined disorder—Epirubicin—bone cancer	0.000232	0.00172	CcSEcCtD
Oxaprozin—Convulsion—Methotrexate—bone cancer	0.000232	0.00172	CcSEcCtD
Oxaprozin—Anaemia—Epirubicin—bone cancer	0.000231	0.00172	CcSEcCtD
Oxaprozin—Flatulence—Doxorubicin—bone cancer	0.000228	0.00169	CcSEcCtD
Oxaprozin—Tension—Doxorubicin—bone cancer	0.000227	0.00169	CcSEcCtD
Oxaprozin—Dysgeusia—Doxorubicin—bone cancer	0.000227	0.00168	CcSEcCtD
Oxaprozin—Malaise—Epirubicin—bone cancer	0.000226	0.00168	CcSEcCtD
Oxaprozin—Methadone—CYP3A4—bone cancer	0.000225	0.0408	CrCbGaD
Oxaprozin—Discomfort—Methotrexate—bone cancer	0.000225	0.00167	CcSEcCtD
Oxaprozin—Nervousness—Doxorubicin—bone cancer	0.000225	0.00167	CcSEcCtD
Oxaprozin—Vertigo—Epirubicin—bone cancer	0.000225	0.00167	CcSEcCtD
Oxaprozin—Syncope—Epirubicin—bone cancer	0.000225	0.00167	CcSEcCtD
Oxaprozin—Leukopenia—Epirubicin—bone cancer	0.000224	0.00166	CcSEcCtD
Oxaprozin—Palpitations—Epirubicin—bone cancer	0.000221	0.00164	CcSEcCtD
Oxaprozin—Confusional state—Methotrexate—bone cancer	0.00022	0.00163	CcSEcCtD
Oxaprozin—Loss of consciousness—Epirubicin—bone cancer	0.00022	0.00163	CcSEcCtD
Oxaprozin—Anaphylactic shock—Methotrexate—bone cancer	0.000218	0.00162	CcSEcCtD
Oxaprozin—Vision blurred—Doxorubicin—bone cancer	0.000218	0.00162	CcSEcCtD
Oxaprozin—Convulsion—Epirubicin—bone cancer	0.000217	0.00161	CcSEcCtD
Oxaprozin—Infection—Methotrexate—bone cancer	0.000217	0.00161	CcSEcCtD
Oxaprozin—Hypertension—Epirubicin—bone cancer	0.000216	0.0016	CcSEcCtD
Oxaprozin—Ill-defined disorder—Doxorubicin—bone cancer	0.000215	0.0016	CcSEcCtD
Oxaprozin—Anaemia—Doxorubicin—bone cancer	0.000214	0.00159	CcSEcCtD
Oxaprozin—Thrombocytopenia—Methotrexate—bone cancer	0.000214	0.00159	CcSEcCtD
Oxaprozin—Anxiety—Epirubicin—bone cancer	0.000212	0.00158	CcSEcCtD
Oxaprozin—Hyperhidrosis—Methotrexate—bone cancer	0.000211	0.00157	CcSEcCtD
Oxaprozin—Discomfort—Epirubicin—bone cancer	0.000211	0.00156	CcSEcCtD
Oxaprozin—Malaise—Doxorubicin—bone cancer	0.000209	0.00155	CcSEcCtD
Oxaprozin—Dry mouth—Epirubicin—bone cancer	0.000208	0.00155	CcSEcCtD
Oxaprozin—Vertigo—Doxorubicin—bone cancer	0.000208	0.00155	CcSEcCtD
Oxaprozin—Anorexia—Methotrexate—bone cancer	0.000208	0.00155	CcSEcCtD
Oxaprozin—Syncope—Doxorubicin—bone cancer	0.000208	0.00154	CcSEcCtD
Oxaprozin—Leukopenia—Doxorubicin—bone cancer	0.000207	0.00154	CcSEcCtD
Oxaprozin—Confusional state—Epirubicin—bone cancer	0.000206	0.00153	CcSEcCtD
Oxaprozin—Palpitations—Doxorubicin—bone cancer	0.000205	0.00152	CcSEcCtD
Oxaprozin—Anaphylactic shock—Epirubicin—bone cancer	0.000204	0.00152	CcSEcCtD
Oxaprozin—Oedema—Epirubicin—bone cancer	0.000204	0.00152	CcSEcCtD
Oxaprozin—Hypotension—Methotrexate—bone cancer	0.000204	0.00151	CcSEcCtD
Oxaprozin—Loss of consciousness—Doxorubicin—bone cancer	0.000204	0.00151	CcSEcCtD
Oxaprozin—Infection—Epirubicin—bone cancer	0.000203	0.00151	CcSEcCtD
Oxaprozin—Shock—Epirubicin—bone cancer	0.000201	0.00149	CcSEcCtD
Oxaprozin—Convulsion—Doxorubicin—bone cancer	0.000201	0.00149	CcSEcCtD
Oxaprozin—Thrombocytopenia—Epirubicin—bone cancer	0.0002	0.00149	CcSEcCtD
Oxaprozin—Hypertension—Doxorubicin—bone cancer	0.0002	0.00148	CcSEcCtD
Oxaprozin—Tachycardia—Epirubicin—bone cancer	0.000199	0.00148	CcSEcCtD
Oxaprozin—Hyperhidrosis—Epirubicin—bone cancer	0.000198	0.00147	CcSEcCtD
Oxaprozin—Insomnia—Methotrexate—bone cancer	0.000197	0.00147	CcSEcCtD
Oxaprozin—Anxiety—Doxorubicin—bone cancer	0.000197	0.00146	CcSEcCtD
Oxaprozin—Paraesthesia—Methotrexate—bone cancer	0.000196	0.00146	CcSEcCtD
Oxaprozin—Discomfort—Doxorubicin—bone cancer	0.000195	0.00145	CcSEcCtD
Oxaprozin—Anorexia—Epirubicin—bone cancer	0.000195	0.00145	CcSEcCtD
Oxaprozin—Dyspnoea—Methotrexate—bone cancer	0.000195	0.00145	CcSEcCtD
Oxaprozin—Somnolence—Methotrexate—bone cancer	0.000194	0.00144	CcSEcCtD
Oxaprozin—Dry mouth—Doxorubicin—bone cancer	0.000193	0.00143	CcSEcCtD
Oxaprozin—Dyspepsia—Methotrexate—bone cancer	0.000192	0.00143	CcSEcCtD
Oxaprozin—Hypotension—Epirubicin—bone cancer	0.000191	0.00142	CcSEcCtD
Oxaprozin—Confusional state—Doxorubicin—bone cancer	0.000191	0.00142	CcSEcCtD
Oxaprozin—Decreased appetite—Methotrexate—bone cancer	0.00019	0.00141	CcSEcCtD
Oxaprozin—Oedema—Doxorubicin—bone cancer	0.000189	0.0014	CcSEcCtD
Oxaprozin—Anaphylactic shock—Doxorubicin—bone cancer	0.000189	0.0014	CcSEcCtD
Oxaprozin—Infection—Doxorubicin—bone cancer	0.000188	0.00139	CcSEcCtD
Oxaprozin—Shock—Doxorubicin—bone cancer	0.000186	0.00138	CcSEcCtD
Oxaprozin—Thrombocytopenia—Doxorubicin—bone cancer	0.000185	0.00137	CcSEcCtD
Oxaprozin—Insomnia—Epirubicin—bone cancer	0.000185	0.00137	CcSEcCtD
Oxaprozin—Tachycardia—Doxorubicin—bone cancer	0.000185	0.00137	CcSEcCtD
Oxaprozin—Paraesthesia—Epirubicin—bone cancer	0.000183	0.00136	CcSEcCtD
Oxaprozin—Hyperhidrosis—Doxorubicin—bone cancer	0.000183	0.00136	CcSEcCtD
Oxaprozin—Dyspnoea—Epirubicin—bone cancer	0.000182	0.00135	CcSEcCtD
Oxaprozin—Somnolence—Epirubicin—bone cancer	0.000182	0.00135	CcSEcCtD
Oxaprozin—Anorexia—Doxorubicin—bone cancer	0.00018	0.00134	CcSEcCtD
Oxaprozin—Feeling abnormal—Methotrexate—bone cancer	0.00018	0.00134	CcSEcCtD
Oxaprozin—Dyspepsia—Epirubicin—bone cancer	0.00018	0.00134	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Methotrexate—bone cancer	0.000179	0.00133	CcSEcCtD
Oxaprozin—Decreased appetite—Epirubicin—bone cancer	0.000178	0.00132	CcSEcCtD
Oxaprozin—Hypotension—Doxorubicin—bone cancer	0.000177	0.00131	CcSEcCtD
Oxaprozin—Constipation—Epirubicin—bone cancer	0.000175	0.0013	CcSEcCtD
Oxaprozin—Urticaria—Methotrexate—bone cancer	0.000173	0.00129	CcSEcCtD
Oxaprozin—Abdominal pain—Methotrexate—bone cancer	0.000173	0.00128	CcSEcCtD
Oxaprozin—Body temperature increased—Methotrexate—bone cancer	0.000173	0.00128	CcSEcCtD
Oxaprozin—Insomnia—Doxorubicin—bone cancer	0.000171	0.00127	CcSEcCtD
Oxaprozin—Paraesthesia—Doxorubicin—bone cancer	0.00017	0.00126	CcSEcCtD
Oxaprozin—Dyspnoea—Doxorubicin—bone cancer	0.000169	0.00125	CcSEcCtD
Oxaprozin—Feeling abnormal—Epirubicin—bone cancer	0.000168	0.00125	CcSEcCtD
Oxaprozin—Somnolence—Doxorubicin—bone cancer	0.000168	0.00125	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Epirubicin—bone cancer	0.000167	0.00124	CcSEcCtD
Oxaprozin—Dyspepsia—Doxorubicin—bone cancer	0.000166	0.00124	CcSEcCtD
Oxaprozin—Decreased appetite—Doxorubicin—bone cancer	0.000164	0.00122	CcSEcCtD
Oxaprozin—Urticaria—Epirubicin—bone cancer	0.000162	0.00121	CcSEcCtD
Oxaprozin—Constipation—Doxorubicin—bone cancer	0.000162	0.0012	CcSEcCtD
Oxaprozin—Abdominal pain—Epirubicin—bone cancer	0.000162	0.0012	CcSEcCtD
Oxaprozin—Body temperature increased—Epirubicin—bone cancer	0.000162	0.0012	CcSEcCtD
Oxaprozin—Asthenia—Methotrexate—bone cancer	0.000157	0.00116	CcSEcCtD
Oxaprozin—Feeling abnormal—Doxorubicin—bone cancer	0.000156	0.00116	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Doxorubicin—bone cancer	0.000155	0.00115	CcSEcCtD
Oxaprozin—Pruritus—Methotrexate—bone cancer	0.000154	0.00115	CcSEcCtD
Oxaprozin—Urticaria—Doxorubicin—bone cancer	0.00015	0.00112	CcSEcCtD
Oxaprozin—Body temperature increased—Doxorubicin—bone cancer	0.000149	0.00111	CcSEcCtD
Oxaprozin—Abdominal pain—Doxorubicin—bone cancer	0.000149	0.00111	CcSEcCtD
Oxaprozin—Diarrhoea—Methotrexate—bone cancer	0.000149	0.00111	CcSEcCtD
Oxaprozin—Asthenia—Epirubicin—bone cancer	0.000147	0.00109	CcSEcCtD
Oxaprozin—Pruritus—Epirubicin—bone cancer	0.000145	0.00107	CcSEcCtD
Oxaprozin—Dizziness—Methotrexate—bone cancer	0.000144	0.00107	CcSEcCtD
Oxaprozin—Diarrhoea—Epirubicin—bone cancer	0.00014	0.00104	CcSEcCtD
Oxaprozin—Vomiting—Methotrexate—bone cancer	0.000139	0.00103	CcSEcCtD
Oxaprozin—Rash—Methotrexate—bone cancer	0.000138	0.00102	CcSEcCtD
Oxaprozin—Dermatitis—Methotrexate—bone cancer	0.000138	0.00102	CcSEcCtD
Oxaprozin—Headache—Methotrexate—bone cancer	0.000137	0.00102	CcSEcCtD
Oxaprozin—Asthenia—Doxorubicin—bone cancer	0.000136	0.00101	CcSEcCtD
Oxaprozin—Dizziness—Epirubicin—bone cancer	0.000135	0.001	CcSEcCtD
Oxaprozin—Pruritus—Doxorubicin—bone cancer	0.000134	0.000993	CcSEcCtD
Oxaprozin—Vomiting—Epirubicin—bone cancer	0.00013	0.000964	CcSEcCtD
Oxaprozin—Nausea—Methotrexate—bone cancer	0.00013	0.000963	CcSEcCtD
Oxaprozin—Diarrhoea—Doxorubicin—bone cancer	0.000129	0.00096	CcSEcCtD
Oxaprozin—Rash—Epirubicin—bone cancer	0.000129	0.000956	CcSEcCtD
Oxaprozin—Dermatitis—Epirubicin—bone cancer	0.000129	0.000956	CcSEcCtD
Oxaprozin—Headache—Epirubicin—bone cancer	0.000128	0.00095	CcSEcCtD
Oxaprozin—Dizziness—Doxorubicin—bone cancer	0.000125	0.000928	CcSEcCtD
Oxaprozin—Nausea—Epirubicin—bone cancer	0.000121	0.000901	CcSEcCtD
Oxaprozin—Vomiting—Doxorubicin—bone cancer	0.00012	0.000892	CcSEcCtD
Oxaprozin—Rash—Doxorubicin—bone cancer	0.000119	0.000885	CcSEcCtD
Oxaprozin—Dermatitis—Doxorubicin—bone cancer	0.000119	0.000884	CcSEcCtD
Oxaprozin—Headache—Doxorubicin—bone cancer	0.000118	0.000879	CcSEcCtD
Oxaprozin—Nausea—Doxorubicin—bone cancer	0.000112	0.000834	CcSEcCtD
